ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

Giaccone Joins Georgetown Lombardi Center

February 22, 2013

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science

February 26, 2010

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady wins RSNA Medal

January 12, 1990